Acceptability and Feasibility of Medical Abortion in Singapore
NCT ID: NCT02985229
Last Updated: 2018-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
130 participants
INTERVENTIONAL
2016-10-31
2017-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acceptability of an Out-patient Regimen of Medical Abortion With Mifepristone and 800 Mcg Misoprostol Administered at 78-84 Days Gestation
NCT01856985
The Extended Gestational Age Medical Abortion Study
NCT00997347
A Pilot of an Outpatient Regimen of Medical Abortion With Mifepristone and Sublingual Misoprostol in the 11 and 12 Weeks
NCT02720991
Chart Review Study of Medical Abortion
NCT02841072
Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation
NCT02314754
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
All participants
All participants in the study will be given the option of home administration of 200 mg oral mifepristone and 800 μg buccal misoprostol for medical abortion.
Mifepristone
The option of home or clinic administration of 200 mg oral mifepristone
Misoprostol
800 μg buccal misoprostol through 70 days LMP following administration of mifepristone
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mifepristone
The option of home or clinic administration of 200 mg oral mifepristone
Misoprostol
800 μg buccal misoprostol through 70 days LMP following administration of mifepristone
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be 21 years of age or over
* Be willing and able to sign consent forms
* Be eligible for abortion according to current hospital guidelines
* Be able to return to the clinic and able to contact study staff or emergency medical services if needed
* Be willing to provide an address, email and/or telephone number for purposes of follow-up
* Agree to comply with the study procedures and visit schedule
Exclusion Criteria
* chronic renal failure
* concurrent long-term corticosteroid therapy
* history of inherited porphyrias
* IUD in place (must be removed after mifepristone is administered).
21 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gynuity Health Projects
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Beverly Winikoff, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Gynuity Health Projects
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
KK Women's and Children's Hospital
Singapore, , Singapore
National University Hospital
Singapore, , Singapore
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1028
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.